Estrategias de abordaje | 12 MAY 18
Manejo del carcinoma de células escamosas del canal anal en estadio I
Las tendencias actuales en el tratamiento de pacientes con cáncer de células escamosas del canal anal en estadio temprano y la asociación entre las diferentes estrategias de manejo y la sobrevida global
Autor/a: Chai CY, Cao HT, Awad S, Massarweh NN JAMA Surg 2018; 153(3): 209-215
Página 1
- Surveillance, Epidemiology, and End Results. Stat fact sheets: anal cancer. http://seer.cancer.gov/statfacts/html/anus.html. Published 2015. Accessed April 12, 2017.
- Glynne-Jones R, Renehan A. Current treatment of anal squamous cell carcinoma. Hematol Oncol Clin North Am. 2012;26(6):1315-1350.
- Nigro ND, Vaitkevicius VK, Considine B Jr. Combined therapy for cancer of the anal canal: a preliminary report. Dis Colon Rectum. 1974;17(3): 354-356.
- National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines). Anal carcinoma. http://www.nccn.org /professionals/physician_gls/pdf/anal.pdf. Accessed March 20, 2017.
- Doyen J, Benezery K, Follana P, et al. Predictive factors for early and late local toxicities in anal cancer treated by radiotherapy in combination with or without chemotherapy. Dis Colon Rectum. 2013; 56(10):1125-1133.
- Bentzen AG, Guren MG, Vonen B, et al. Faecal incontinence after chemoradiotherapy in anal cancer survivors: long-term results of a national cohort. Radiother Oncol. 2013;108(1):55-60.
- Tannock IF. Treatment of cancer with radiation and drugs. J Clin Oncol. 1996;14(12):3156-3174.
- Devisetty K, Mell LK, Salama JK, et al. A multi-institutional acute gastrointestinal toxicity analysis of anal cancer patients treated with concurrent intensity-modulated radiation therapy (IMRT) and chemotherapy. Radiother Oncol. 2009; 93(2):298-301.
- Cummings BJ, Harwood AR, Keane TJ, Thomas GM, Rider WD. Combined treatment of squamous cell carcinoma of the anal canal: radical radiation therapy with 5-fluorouracil and mitomycin-C, a preliminary report. Dis Colon Rectum. 1980;23(6): 389-391.
- Nigro ND, Seydel HG, Considine B, Vaitkevicius VK, Leichman L, Kinzie JJ. Combined preoperative radiation and chemotherapy for squamous cell carcinoma of the anal canal. Cancer. 1983;51(10): 1826-1829.
- UKCCCR Anal Cancer TrialWorking Party. Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. Lancet. 1996;348(9034):1049-1054.
- Bartelink H, Roelofsen F, Eschwege F, et al. Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups. J Clin Oncol. 1997;15(5):2040-2049.
- Flam M, John M, Pajak TF, et al. Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study. J Clin Oncol. 1996;14 (9):2527-2539.
- Gunderson LL, Winter KA, Ajani JA, et al. Long-term update of US GI intergroup RTOG 98-11 phase III trial for anal carcinoma: survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil/mitomycin versus fluorouracil/cisplatin. J Clin Oncol. 2012;30 (35):4344-4351.
- James RD, Glynne-Jones R, Meadows HM, et al. Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2 × 2 factorial trial. Lancet Oncol. 2013;14(6):516-5
Comentarios
Para ver los comentarios de sus colegas o para expresar su opinión debe ingresar con su cuenta de IntraMed.
Términos y condiciones de uso | Política de privacidad | Todos los derechos reservados | Copyright 1997-2024